Seeking Alpha

Spencer Osborne

 
View as an RSS Feed
View Spencer Osborne's Comments BY TICKER:
Latest  |  Highest rated
  • Arena Revises SEC Filing On APD811 [View article]
    Plain....

    Yes, I am long the stock.

    What this article points out is that this mistake by management is something that is not good, and that it will be used by the bear side as a tool. This type of mistake should NEVER happen. To omit something minor is one thing....to omit a serious adverse event in a trial that had so few people is a screw-up that should have never happened.

    The excuses some over-passionate longs come up with are mind numbing!

    Do you want to crucify me for letting investors know about this?

    Trusting management....I do not "trust" management of ANY public company. Anyone that does is being foolish. I have levels of trust that I apply to a company. An event like this, and the announcement of the withdrawal of the European application, take my trust level in this management down a bit.
    Aug 29, 2013. 01:43 PM | 1 Like Like |Link to Comment
  • Arena Revises SEC Filing On APD811 [View article]
    Plain.....

    As I stated, and I do not know how much more clearly I could state it unless I bold it.....
    _____For investors in Arena, this event is not good news. While there is a chance that the event may not have been study related, the fact that the company had to change its stance on the SEC filing puts a big focus on the event that may not have otherwise existed. Of course, this article also calls attention to the matter, but it is prudent for investors to understand this dynamic. In my opinion, had the event been included in the first SEC filing, it would have been digested and accepted by the Street. Now, we have a whole series of question marks that will develop. We have gone from a typical study that will bring about a host of positive and negative data to a situation where there's appearance of some discord within the company._______

    From an investment standpoint I do not care if 1 person complained of a hang nail. The issue here is not whether 39 out of 40 or 30 out of 40 had no heart issue. The issue is PLAIN AND SIMPLE that what the company did with the press release and 8K filings LOOKS BAD.

    To characterize the event as an "unpleasant event" is spin in its finest form. It was a serious adverse event.

    You know darn well that this event was KNOWN prior to press releases being issued. KEEP IT REAL!!!!!

    Do you actually believe that on Tuesday that the company was not aware of the events of one of its own trials PRIOR to issuing the press release? Do you REALLY believe that the press release is issued without the input and report from the STUDY INVESTIGATOR?

    EXCUSES are not good.
    Aug 29, 2013. 12:41 PM | 2 Likes Like |Link to Comment
  • Arena Revises SEC Filing On APD811 [View article]
    user....

    not to add fuel to the fire, but the manner in which the withdrawal of the application in Europe (disclosed in a quarterly conf. call) was not the best handling of a situation either. Investors got blindsided on that one.

    As these types of things add up a pattern develops.
    Aug 29, 2013. 11:58 AM | 6 Likes Like |Link to Comment
  • Arena Revises SEC Filing On APD811 [View article]
    tgallo.....

    I am simply saying that the series of events here is something that can CREATE mistrust and doubt. As I stated, had the original filing contained this information it would not be as big of an issue.

    Sometimes the appearance of things is more important.

    The other 39 patients appear to have had good results with side effects being headache, nausea and jaw pain. The results seem to be good enough to continue trials.

    1 out of 40 is 2.5%. May or may not be a big deal.

    Failing to file correctly and disclose such information is a big deal.
    Aug 29, 2013. 11:41 AM | 3 Likes Like |Link to Comment
  • Arena Revises SEC Filing On APD811 [View article]
    tgallo....

    oh my god.....are we really to the point of trying to explain away and develop excuses for what was a very poor decision by management regarding a serious adverse event???????? Really??????

    The bottom line is that if this was reported in the first place we would:

    A) have not seen the drop below 52 week lows
    B) would not have the trust of management questioned
    and
    C) not have the potential impact where this faux pas passes on to something else (i.e. application for Belviq in Europe) A concern there was heart issues, and it now appears that Arena is hiding issues. This is not good when you have a bunch of applications pending with various countries and one of the concerns (right or wrong) is heart issues.
    Aug 29, 2013. 11:18 AM | 1 Like Like |Link to Comment
  • Arena Revises SEC Filing On APD811 [View article]
    tgallo.....

    This is what I stated

    "While there is a chance that the event may not have been study related, the fact that the company had to change its stance on the SEC filing puts a big focus on the event that may not have otherwise existed."

    From an investment standpoint I do not about how common or uncommon any given condition is. The issue here from an investment standpoint it the appearance of hiding something initially. That is not good and challenges trust in what we are told.
    Aug 29, 2013. 11:09 AM | 1 Like Like |Link to Comment
  • Arena Revises SEC Filing On APD811 [View article]
    tgallo.....

    Don't spin it. It is not good news.

    Yes, I am well aware that PAH is a serious condition. So are many other things.

    The bigger issue is that there is now a perception that there was something being hidden. There is no excuse that is acceptable for issuing a PR and an 8K saying all is good, and then hours later saying that there was something bad in the study. This was a known issue to the company and had they disclosed it initially it would not have become a focal point.
    Aug 29, 2013. 11:04 AM | 3 Likes Like |Link to Comment
  • Arena Revises SEC Filing On APD811 [View article]
    ganres....

    So you have the stance that it is "not serious". That is fine. Arena disagrees with you.
    Aug 29, 2013. 10:59 AM | 2 Likes Like |Link to Comment
  • Arena Revises SEC Filing On APD811 [View article]
    tgallo....

    a lung patient had a heart issue
    Aug 29, 2013. 10:57 AM | 1 Like Like |Link to Comment
  • Arena Revises SEC Filing On APD811 [View article]
    upbeat....

    You can certainly have an opinion. I do not write on a daily basis. Here is my coverage this month.

    12 articles, 1 of which covered the conference call and 4 of which covered the weekly sales data figures, 1 yesterday calling it a buy on the ADP811 news, and this one covering the refile of the 8K.
    Aug 29, 2013. 10:56 AM | 2 Likes Like |Link to Comment
  • Arena Revises SEC Filing On APD811 [View article]
    Don....

    What is being reported, BY ARENA, is that they had a major adverse event relating to the heart. It was an event that they chose to not report initially, and have now decided to disclose.
    Aug 29, 2013. 10:41 AM | 1 Like Like |Link to Comment
  • Arena Revises SEC Filing On APD811 [View article]
    gan....

    I would not characterize it as not serious. Did you read the link in the piece. Someone that has had such an event is much more likely to have a condition within a year of discharge.

    Here is more:
    http://1.usa.gov/18729vR

    http://1.usa.gov/1872bnJ
    Aug 29, 2013. 09:43 AM | Likes Like |Link to Comment
  • Arena Revises SEC Filing On APD811 [View article]
    The 8K was filed at 6:00 AM. The news is now 3 hours old
    Aug 29, 2013. 09:30 AM | 3 Likes Like |Link to Comment
  • Is Arena A Buy Near 52-Week Lows? [View article]
    stein...

    Advertising is the responsibility and at the expense of Eisai.
    Aug 28, 2013. 10:31 PM | Likes Like |Link to Comment
  • Is Arena A Buy Near 52-Week Lows? [View article]
    IP....

    I would imagine 100,000 in q3
    Aug 28, 2013. 06:42 PM | 2 Likes Like |Link to Comment
COMMENTS STATS
7,652 Comments
5,988 Likes